These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Keeping it real with investors. Dipp M; Westphal C; Mirkin C; Baker J; Harper T; Harris C Nat Biotechnol; 2006 Feb; 24(2):133-5. PubMed ID: 16526102 [No Abstract] [Full Text] [Related]
7. Medical technology & spending: the next market bubble? Dentzer S Health Aff (Millwood); 2008; 27(6):1464-5. PubMed ID: 18997200 [No Abstract] [Full Text] [Related]
9. 2006: a stellar year for financing. Lawrence S Nat Biotechnol; 2007 Feb; 25(2):156. PubMed ID: 17287738 [No Abstract] [Full Text] [Related]
10. Europe needs a single, deep capital market. Hodgson J Nat Biotechnol; 2002 Oct; 20(10):960-1. PubMed ID: 12355101 [No Abstract] [Full Text] [Related]
11. Venture capital for the pharmacologist. Miller LG Mol Interv; 2001 Dec; 1(5):242-4. PubMed ID: 14993362 [No Abstract] [Full Text] [Related]
12. Looking at US versus European exit opportunities. Lawrence S Nat Biotechnol; 2005 Oct; 23(10):1203. PubMed ID: 16302294 [No Abstract] [Full Text] [Related]
13. Mind the (biomedical funding) gap. Klausner A Nat Biotechnol; 2005 Oct; 23(10):1217-8. PubMed ID: 16211055 [No Abstract] [Full Text] [Related]
14. Biotechs await single European financial market. Louët S Nat Biotechnol; 2003 Dec; 21(12):1417. PubMed ID: 14647312 [No Abstract] [Full Text] [Related]
15. Life support for life science innovation? Nat Biotechnol; 2007 Feb; 25(2):144. PubMed ID: 17287731 [TBL] [Abstract][Full Text] [Related]
16. 2005: biotech partners up. Lawrence S Nat Biotechnol; 2006 Feb; 24(2):126. PubMed ID: 16465145 [No Abstract] [Full Text] [Related]
17. VC funding hits high in Q1. Lawrence S Nat Biotechnol; 2007 May; 25(5):496. PubMed ID: 17483825 [No Abstract] [Full Text] [Related]